Peptides for cancer treatment
US11591368B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 27, 2018 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Apr 27, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention pertains to cancer treatment or prevention field. Particularly, the invention provides peptide fragments from SLIT2 protein and their applications in inhibition of cancer growth, invasion and metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.